Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial.
SOSoodabeh Omidvar TehraniMGMahboobeh Ghasemzadeh RahbardarKSKamran ShoorgashtiMJMohammad Javad Dehghan NayeriAHAmir Hooshang Mohammadpour
Mashhad University of Medical Sciences
Indexed indoajpubmed
Abstract
Objective
Severe disease onset of COVID-19 may result in alveolar injury and respiratory failure. Apoptosis and inflammation are the main causes of respiratory distress syndrome. Berberine is used in medicine as an analgesic, anti-asthmatic, anti-inflammatory, and antiviral. In the current investigation, the effect of berberine on COVID-19 outpatients was studied.
Materials And Methods
. The severity and frequency of these symptoms and the level of the parameters were statistically compared between the two groups.
Citation impact
5
total citations
- FWCI
- 0.00
- Percentile
- 98%
- References
- 34
Too recent for citation history.
Authors
6- SOSoodabeh Omidvar TehraniCorresponding
Mashhad University of Medical Sciences
- MGMahboobeh Ghasemzadeh Rahbardar
Mashhad University of Medical Sciences
- KSKamran Shoorgashti
Mashhad University of Medical Sciences
- MJMohammad Javad Dehghan Nayeri
Mashhad University of Medical Sciences
- AHAmir Hooshang Mohammadpour
Mashhad University of Medical Sciences
Topics & keywords
Topics
Keywords
- Berberine
- Medicine
- Sore throat
- Nausea
- Placebo
- Internal medicine
- Respiratory distress
- Dose
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.